论文信息 - Weekly high-dose erlotinib in patients with non-small cell lung cancer (NSCLC): A phase I/II study. - 字舞流文

Weekly high-dose erlotinib in patients with non-small cell lung cancer (NSCLC): A phase I/II study.

M. Kris | C. Azzoli | V. Miller | N. Rizvi | L. Krug | D. Ramies | R. Heelan | J. Gomez | D. Milton | M. Dunne